Fig. 2From: Comparison of two independent systematic reviews of trials of recombinant human bone morphogenetic protein-2 (rhBMP-2): the Yale Open Data Access Medtronic ProjectForest plots from Center A and Center B meta-analyses examining likelihood of bone fusion and cancer risk associated with rhBMP-2Back to article page